Advertisement

Thiamine Deficiency: A Model of Metabolic Encephalopathy and of Selective Neuronal Vulnerability

  • Saravanan Karuppagounder
  • Gary E. Gibson
Chapter

Summary

Thiamine (vitamin B1) deficiency (TD) is a unique example of a nutritional deficit that produces a generalized impairment in oxidative metabolism and leads to metabolic encephalopathy or delirium, memory deficits and selective neuronal death in particular brain regions. Experimental TD is a classical model of a nutritional deficit associated with a generalized impairment of oxidative metabolism and selective cell loss in the brain. The response to TD is altered by the genetic background (i.e., strain) and the age of the animal. Changes in thiamine-dependent processes have also been implicated in ischemia (stroke), diabetes and multiple neurodegenerative disorders. An understanding of the mechanism by which TD leads to brain dysfunction and eventually to selective neuronal death is likely to facilitate our understanding of the role of thiamine in all these disorders. In addition, the results are likely to help our understanding of the fundamental mechanisms leading to altered neuronal functions and neuronal death in these other disorders.

Keywords

Neuronal Death Mitochondrial Permeability Transition Pore Mitochondrial Permeability Transition Pore Thiamine Deficiency Cerebellar Granule Neuron 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Alcaide, M. L., et al., 2003. Wernicke’s encephalopathy in AIDS: a preventable cause of fatal neurological deficit. Int J STD AIDS. 14, 712–713.PubMedCrossRefGoogle Scholar
  2. Alves, L. F., et al., 2006. [Beriberi after bariatric surgery: not an unusual complication. Report of two cases and literature review]. Arq Bras Endocrinol Metabol. 50, 564–568.PubMedCrossRefGoogle Scholar
  3. Andreassen, O. A., et al., 2001. Dichloroacetate exerts therapeutic effects in transgenic mouse models of Huntington’s disease. Ann Neurol. 50, 112–117.PubMedCrossRefGoogle Scholar
  4. Balaghi, M., Pearson, W. N., 1966. Tissue and intracellular distribution of radioactive thiamine in normal and thiamine-deficient rats. J Nutr. 89, 127–132.PubMedGoogle Scholar
  5. Barclay, L. L., Gibson, G. E., 1982. Spontaneous open-field behavior in thiamin-deficient rats. J Nutr. 112, 1899–1905.PubMedGoogle Scholar
  6. Barclay, L. L., et al., 1981a. Impairment of behavior and acetylcholine metabolism in thiamine deficiency. J Pharmacol Exp Ther. 217, 537–543.Google Scholar
  7. Barclay, L. L., et al., 1981b. The string test: an early behavioral change in thiamine deficiency. Pharmacol Biochem Behav. 14, 153–157.CrossRefGoogle Scholar
  8. Barclay, L. L., et al., 1982. Cholinergic therapy of abnormal open-field behavior in thiamin-deficient rats. J Nutr. 112, 1906–1913.PubMedGoogle Scholar
  9. Blass, J. P., Gibson, G. E., 1977. Abnormality of a thiamine-requiring enzyme in patients with Wernicke-Korsakoff syndrome. N Engl J Med. 297, 1367–1370.PubMedCrossRefGoogle Scholar
  10. Blass, J. P., Gibson, G. E., 1979. Genetic factors in Wernicke-Korsakoff syndrome. Alcohol Clin Exp Res. 3, 126–134.PubMedCrossRefGoogle Scholar
  11. Blass, J. P., et al., 1975. Clinical and metabolic abnormalities accompanying deficiencies in pyruvate oxidation. F.A. Hommes (ed.)Academic Press, New York, pp. 193Google Scholar
  12. Bubber, P., et al., 2005. Mitochondrial abnormalities in Alzheimer brain: mechanistic implications. Ann Neurol. 57, 695–703.PubMedCrossRefGoogle Scholar
  13. Bublitz, C., Steavenson, S., 1988. The pentose phosphate pathway in the endoplasmic reticulum. J Biol Chem. 263, 12849–12853.PubMedGoogle Scholar
  14. Butterworth, R. F., et al., 1993. Thiamine-dependent enzyme changes in the brains of alcoholics: relationship to the Wernicke-Korsakoff syndrome. Alcohol Clin Exp Res. 17, 1084–1088.PubMedCrossRefGoogle Scholar
  15. Calingasan, N. Y., Gibson, G. E., 2000aDietary restriction attenu-ates the neuronal loss,  induction of heme oxygenase-1 and blood-brain barrier breakdown induced by impaired oxidative metabolism. Brain Res. 885, 62–69.CrossRefGoogle Scholar
  16. Calingasan, N. Y., Gibson, G. E., 2000b. Vascular endothelium is a site of free radical production and inflammation in areas of neuronal loss in thiamine-deficient brain. Ann N Y Acad Sci. 903,53–356.CrossRefGoogle Scholar
  17. Calingasan, N. Y., et al., 1994a. Distribution of the alpha-ketoglutarate dehydrogenase complex in rat brain. J Comp Neurol. 346, 461–479.CrossRefGoogle Scholar
  18. Calingasan, N. Y., et al., 1994b. Selective enrichment of cholinergic neurons with the alphaketoglutarate dehydrogenase complex in rat brain. Neurosci Lett. 168, 209–212.CrossRefGoogle Scholar
  19. Calingasan, N. Y., et al., 1995a. Blood-brain barrier abnormalities in vulnerable brain regions during thiamine deficiency. Exp Neurol. 134, 64–72.CrossRefGoogle Scholar
  20. Calingasan, N. Y., et al., 1995b. Accumulation of amyloid precursor protein-like immunoreactivity in rat brain in response to thiamine deficiency. Brain Res. 677, 50–60.CrossRefGoogle Scholar
  21. Calingasan, N. Y., et al., 1995c. Heterogeneous expression of transketolase in rat brain. J Neurochem. 64, 1034–1044.CrossRefGoogle Scholar
  22. Calingasan, N. Y., et al., 1996. Novel neuritic clusters with accmu-lations of amyloid precursor protein and amyloid accmu-lations of amyloid precursor protein and amyloid precursor-like protein 2 immunoreactivity in brain regions damaged by thiamine deficiency precursor-like protein 2 immunoreactivity in brain regions damaged by thiamine deficiency. Am J Pathol. 149, 1063–1071.PubMedGoogle Scholar
  23. Calingasan, N. Y., et al.,1998. Induction of nitric oxide synthase and microglial responses precede selective cell death induced by chronic impairment of oxidative metabolism.Am J Pathol.153,599–610.PubMedCrossRefGoogle Scholar
  24. Calingasan, N. Y., et al., 1999. Oxidative stress is associated with region-specific neuronal death during thiamine deficiency. J Neuropathol Exp Neurol. 58, 946–958.PubMedCrossRefGoogle Scholar
  25. Calingasan, N. Y., et al., 2000. Vascular factors are critical in selective neuronal loss in an animal model of impaired oxidative metabolism. J Neuropathol Exp Neurol. 59, 207–217.PubMedGoogle Scholar
  26. Coy, J. F., et al., 2005. Mutations in the transketolase-like gene TKTL1: clinical implications for neurodegenerative diseases, diabetes and cancer. Clin Lab. 51, 257–273.PubMedGoogle Scholar
  27. Desjardins, P., Butterworth, R. F., 2005. Role of mitochondrial dysfunction and oxidative stress in the pathogenesis of selective neuronal loss in Wernicke’s encephalopathy. Mol Neurobiol. 31,17–25.PubMedCrossRefGoogle Scholar
  28. Falk, R. E., et al., 1976. Ketonic diet in the management of pyruvate dehydrogenase deficiency. Pediatrics. 58, 713–721.PubMedGoogle Scholar
  29. Foldi, M., et al., 2007. Transketolase protein TKTL1 overexpression: A potential biomarker and therapeutic target in breast cancer. Oncol Rep. 17, 841–845.PubMedGoogle Scholar
  30. Freeman, G. B., et al., 1987. Effect of age on behavioral and enzymatic changes during thiamin deficiency. Neurobiol Aging. 8, 429–434.PubMedCrossRefGoogle Scholar
  31. Gibson, G. E., Blass, J. P., 1976. Impaired synthesis of acetylcholine in brain accompanying mild hypoxia and hypoglycemia. J Neurochem. 27, 37–42.PubMedCrossRefGoogle Scholar
  32. Gibson, G. E., Blass, J. P. , 2007. Thiamine-dependent processe and treatment strategies in neurodegeneration. Antioxid Redox Signal. 9, 1605–1619.PubMedCrossRefGoogle Scholar
  33. Gibson, G. E., et al., 1975. Decreased synthesis of acetylcholine accompanying impaired oxidation of pyruvic acid in rat brain minces. Biochem J. 148, 17–23.PubMedGoogle Scholar
  34. Gibson, G. E., et al., 1983. Cholinergic drugs and 4-aminopyridine alter hypoxic-induced behavioral deficits. Pharmacol Biochem Behav. 18, 909–916.PubMedCrossRefGoogle Scholar
  35. Gibson, G. E., et al., 1984. Correlation of enzymatic, metabolic, and behavioral deficits in thiamin deficiency and its reversal. Neurochem Res. 9, 803–814.PubMedCrossRefGoogle Scholar
  36. Gibson, G. E., et al., 1988. Reduced activities of thiamine-dependent enzymes in the brains and peripheral tissues of patients with Alzheimer’s disease. Arch Neurol. 45, 836–840.PubMedCrossRefGoogle Scholar
  37. Gibson, G., et al., 1989. Regionally selective alterations in enzymatic activities and metabolic fluxes during thiamin deficiency. Neurochem Res. 14, 17–24.PubMedCrossRefGoogle Scholar
  38. Gibson, G. E., et al., 1999. Oxidative stress and a key metabolic enzyme in Alzheimer brains, cultured cells, and an animal model of chronic oxidative deficits. Ann N Y Acad Sci. 893, 79–94.PubMedCrossRefGoogle Scholar
  39. Gibson, G. E., et al., 2003. Deficits in a tricarboxylic acid cycle enzyme in brains from patients with Parkinson’s disease. Neurochem Int. 43, 129–135.PubMedCrossRefGoogle Scholar
  40. Hammes, H. P., et al., 2003. Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. Nat Med. 9, 294–299.PubMedCrossRefGoogle Scholar
  41. Hazell, A. S., Wang, C., 2005. Downregulation of complexin I and complexin II in the medial thalamus is blocked by N-acetylcysteine in experimental Wernicke’s encephalopathy. J Neurosci Res. 79, 200–207.PubMedCrossRefGoogle Scholar
  42. Hazell, A. S., et al., 1993. Cerebral vulnerability is associated with selective increase in extracellular glutamate concentration in experimental thiamine deficiency. J Neurochem. 61, 1155–1158.PubMedCrossRefGoogle Scholar
  43. Hazell, A. S., et al., 2003. Thiamine deficiency results in downregulation of the GLAST glutamate transporter in cultured astrocytes. Glia. 43, 175–184.PubMedCrossRefGoogle Scholar
  44. Heroux, M., et al., 1996. Alterations of thiamine phosphorylation and of thiamine-dependent enzymes in Alzheimer’s disease. Metab Brain Dis. 11, 81–88.PubMedCrossRefGoogle Scholar
  45. Huang, H. M., et al. , 2003. Inhibition of alpha-ketoglutarate dehydrogenase complex promotes cytochrome c release from mitochondria, caspase-3 activation, and necrotic cell death. J Neurosci Res. 11, 74̉317.PubMedCrossRefGoogle Scholar
  46. Huang, H. M., et al., 2005. Selective antioxidants differentially modify endoplasmic reticulum Ca2+ stores and capacitative calcium entry. Soc Neurosci. 35, 93–100.Google Scholar
  47. Jeitner, T. M., et al. , 2005. Inhibition of the alpha-ketoglutarate dehydrogenase complex by the myeloperoxidase products, hypochlorous acid and mono-N-chloramine. J Neurochem. 92, 302–310.PubMedCrossRefGoogle Scholar
  48. Jimenez-Jimenez, F. J., et al., 1999. Cerebrospinal fluid levels of thiamine in patients with Parkinson’s disease. Neurosci Lett. 271, 33–36.PubMedCrossRefGoogle Scholar
  49. Karachalias, N., et al., 2005. High-dose thiamine therapy counters dyslipidemia and advanced glycation of plasma protein in streptozotocin-induced diabetic rats. Ann N Y Acad Sci. 1043, 777–783.PubMedCrossRefGoogle Scholar
  50. Kark, R. A., et al., 1975. Experimental thiamine deficiency. Neuropathic and mitochondrial changes induced in rat muscle. Arch Neurol. 32, 818–825.PubMedCrossRefGoogle Scholar
  51. Karuppagounder, S. S., et al., 2006. Mild impairment of oxidative metabolism exacerbates pathology in a transgenic model of plaque formation. Soc Neurosci. 36, 170–715.Google Scholar
  52. Karuppagounder, S. S., et al., 2007. Changes in inflammatory processes associated with selective vulnerability following mild impairment of oxidative metabolism. Neurobiol Dis. 26, 353–362.PubMedCrossRefGoogle Scholar
  53. Karuppagounder, S. S., et al. , 2008. Translocation of Amyloid Precursor Protein C-terminal Fragment(s) to the Nucleus Precedes Neuronal Death due to Thiamine Deficiency-induced Mild Impairment of Oxidative Metabolism Mild Impairment of Oxidative Metabolism. Neurochemical research, 33, 1365–1372.PubMedCrossRefGoogle Scholar
  54. Ke, Z. J., Gibson, G. E., 2004. Selective response of various brain cell types during neurodegeneration induced by mild impairment of oxidative metabolism. Neurochem Int. 45, 361–369.PubMedCrossRefGoogle Scholar
  55. Ke, Z. J., et al., 2003. Reversal of thiamine deficiency-induced neurodegeneration. J Neuropathol Exp Neurol. 62, 195–207.PubMedGoogle Scholar
  56. Ke, Z. J., et al., 2005a. CD40-CD40L interactions promote neuronal death in a model of neurodegeneration due to mild impairment of oxidative metabolism. Neurochem Int. 47, 204–215.CrossRefGoogle Scholar
  57. Ke, Z. J., et al., 2005b. CD40L deletion delays neuronal death in a model of neurodegeneration due to mild impairment of oxidative metabolism. J Neuroimmunol. 164, 85–92.CrossRefGoogle Scholar
  58. Ke, Z. J., et al., 2006. Peripheral inflammatory mechanisms modulate microglial activation in response to mild impairment of oxidative metabolism. Neurochem Int. 49, 548–556.PubMedCrossRefGoogle Scholar
  59. Klivenyi, P., et al., 2004. Mice deficient in dihydrolipoamide dehydrogenase show increased vulnerability to MPTP, malonate and 3-nitropropionic acid neurotoxicity. J Neurochem. 88, 1352–1360.PubMedCrossRefGoogle Scholar
  60. Langlais, P. J., Mair, R. G., 1990. Protective effects of the glutamate antagonist MK-801 on pyrithiamine-induced lesions and amino acid changes in rat brain. J Neurosci. 10, 1664–1674.PubMedGoogle Scholar
  61. Langlais, P. J., Savage, L. M., 1995. Thiamine deficiency in rats produces cognitive and memory deficits on spatial tasks that correlate with tissue loss in diencephalon, cortex and white matter. Behav Brain Res. 68, 75–89.PubMedCrossRefGoogle Scholar
  62. Lee, B. Y., et al., 2005. Thiamin deficiency: a possible major cause of some tumors? (review). Oncol Rep. 14, 1589–1592.PubMedGoogle Scholar
  63. Martin, E., et al., 2005. Pyruvate dehydrogenase complex: metabolic link to ischemic brain injury and target of oxidative stress. J Neurosci Res. 79, 240–247.PubMedCrossRefGoogle Scholar
  64. Mastrogiacomo, F., Kish, S. J., 1994. Cerebellar alpha-ketoglutarate dehydrogenase activity is reduced in spinocerebellar ataxia type 1. Ann Neurol. 35, 624–626.PubMedCrossRefGoogle Scholar
  65. McLure, K. G., et al., 2004. NAD+ modulates p53 DNA binding specificity and function. Mol Cell Biol. 24, 9958–9967.PubMedCrossRefGoogle Scholar
  66. McRee, R. C., et al., 2000. Increased histamine release and granulocytes within the thalamus of a rat model of Wernicke’s encephalopathy. Brain Res. 858, 227–236.PubMedCrossRefGoogle Scholar
  67. Meng, J. S., Okeda, R., 2003. Neuropathological study of the role of mast cells and histaminepositive neurons in selective vulnerability of the thalamus and inferior colliculus in thiaminedeficient encephalopathy. Neuropathology. 23, 25–35.PubMedCrossRefGoogle Scholar
  68. Nakagawasai, O., et al. , 2000a. Immunohistochemical estimation of brain choline acetyltransferase and somatostatin related to the impairment of avoidance learning induced by thiamine deficiency.Brain Res Bull 52,189–196. CrossRefGoogle Scholar
  69. Nakagawasai, O., et al., 2000b. Immunohistochemical estimation of rat brain somatostatin on avoidance learning impairment induced by thiamine deficiency. Brain Res Bull. 51, 47–55.CrossRefGoogle Scholar
  70. Neufeld, E. J., et al., 2001. Thiamine-responsive megaloblastic anemia syndrome: a disorder of high-affinity thiamine transport. Blood Cells Mol Dis. 27, 135–138.PubMedCrossRefGoogle Scholar
  71. Pannunzio, P., et al., 2000. Thiamine deficiency results in metabolic acidosis and energy failure in cerebellar granule cells: an in vitro model for the study of cell death mechanisms in Wernicke’s encephalopathy. J Neurosci Res. 62, 286–292.PubMedCrossRefGoogle Scholar
  72. Park, L. C., et al., 2000. Metabolic impairment elicits brain cell type-selective changes in oxidative stress and cell death in culture. J Neurochem. 74, 114–124.PubMedCrossRefGoogle Scholar
  73. Park, L. C., et al., 2001a. Mitochondrial impairment in the cerebellum of the patients with progressive supranuclear palsy. J Neurosci Res. 66, 1028–1034.CrossRefGoogle Scholar
  74. Park, L. C., et al., 2001b. Co-culture with astrocytes or microglia protects metabolically impaired neurons. Mech Ageing Dev. 123, 21–27.CrossRefGoogle Scholar
  75. Pawlik, F., et al., 1977. Peripheral nerve changes in thiamine deficiency and starvation. Acta Neuropathologica. 39, 211–218.PubMedCrossRefGoogle Scholar
  76. Roland, J. J., Savage, L. M., 2007. Blunted hippocampal, but not striatal, acetylcholine efflux parallels learning impairment in diencephalic-lesioned rats. Neurobiol Learn Mem. 87, 123–132.CrossRefGoogle Scholar
  77. Savage, L. M., et al., 2007. Selective septohippocampal — but not forebrain amygdalar — cholinergic dysfunction in diencephalic amnesia. Brain Res. 1139, 210–219.PubMedCrossRefGoogle Scholar
  78. Sheline, C. T., Wei, L., 2006. Free radical-mediated neurotoxicity may be caused by inhibition of mitochondrial dehydrogenases in vitro and in vivo. Neuroscience. 140, 235–246.PubMedCrossRefGoogle Scholar
  79. Sheline, C. T., et al., 2002. Cofactors of mitochondrial enzymes attenuate copper-induced death in vitro and in vivo. Ann Neurol. 52, 195–204.PubMedCrossRefGoogle Scholar
  80. Sheu, K. F., et al., 1996. Regional reductions of transketolase in thiamine-deficient rat brain. J Neurochem. 67, 684–691.PubMedCrossRefGoogle Scholar
  81. Shi, Q., et al., 2007. Responses of the mitochondrial alpha-ketoglutarate dehydrogenase complex to thiamine deficiency may contribute to regional selective vulnerability. Neurochem Int. 50, 921–931.PubMedCrossRefGoogle Scholar
  82. Shin, B. H., et al., 2004. Thiamine attenuates hypoxia-induced cell death in cultured neonatal rat cardiomyocytes. Mol Cells. 18, 133–140.PubMedGoogle Scholar
  83. Shneider, A. B., 1991. [Anti-ischemic heart protection using thiamine and nicotinamide]. Patol Fiziol Eksp Ter. 9–10.Google Scholar
  84. Starkov, A. A., et al., 2004. Mitochondrial alpha-ketoglutarate dehydrogenase complex generates reactive oxygen species. J Neurosci. 24, 7779–2788.PubMedCrossRefGoogle Scholar
  85. Todd, K. G., Butterworth, R. F., 1999. Early microglial response in experimental thiamine deficiency: an immunohistochemical analysis. Glia. 25, 190–198.PubMedCrossRefGoogle Scholar
  86. Ueda, K., et al., 2006. Severe thiamine deficiency resulted in Wernicke’s encephalopathy in a chronic dialysis patient. Clin Exp Nephrol. 10, 290–293.PubMedCrossRefGoogle Scholar
  87. Victor, M., et al., 1971. The Wernicke-Korsakoff syndrome. A clinical and pathological study of  245 patients, 82 with post-mortem examinations. Contemp Neurol Ser. 7, 1–206.PubMedGoogle Scholar
  88. Wang, C., et al., 2007a. Effect of ascorbic acid and thiamine supplementation at different concentrations on lead toxicity in liver. Ann Occup Hyg. 51, 563–569.CrossRefGoogle Scholar
  89. Wang, X., et al., 2007b. Activation of double-stranded RNA-activated protein kinase by mild impairment of oxidative metabolism in neurons. J Neurochem. 103, 2380–2390.CrossRefGoogle Scholar
  90. Wang, X., et al., 2007c. Thiamine deficiency induces endoplasmic reticulum stress in neurons. Neuroscience. 144, 1045–1056.CrossRefGoogle Scholar
  91. Yates, C. M., et al., 1990. Enzyme activities in relation to pH and lactate in postmortem brain in Alzheimer-type and other dementias. J Neurochem. 55, 1624–1630.PubMedCrossRefGoogle Scholar
  92. Zhao, N., et al., 2007. Impaired hippocampal neurogenesis is involved in cognitive dysfunction induced by thiamine deficiency at early pre-pathological lesion stage. Neurobiol Dis. 29, 176–185.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Saravanan Karuppagounder
    • 1
  • Gary E. Gibson
    • 1
  1. 1.Weill Medical College of Cornell University, Burke Medical Research InstituteWhite PlainsUSA

Personalised recommendations